John Jain
John K. Jain, MD, FACOG is an American board-certified reproductive endocrinologist and a pioneer in the field of reproductive medicine. He was federally funded by the National Institutes of Health (NIH) and was appointed to the National Ethics Committee of the American College of Obstetricians by President Vivian Dickerson. In 2006, the Pacific Coast Reproductive Society awarded him its top research prize.
Jain is one of four reproductive endocrinologists to be named to the National Scientific Advisory Council of Fertility Preservation by the NIH. Additionally, he was a member of the grants review panel for the Global Microbicides Program of the National Institute of Child Health and Human Development.
Jain has twenty years of academic experience including a decade as a decorated professor of Obstetrics and Gynecology at the USC Keck School of Medicine. During his tenure at USC, he spearheaded egg freezing research and subsequently created the university’s egg freezing program. He now brings that expertise to Santa Monica Fertility.
He remains dedicated to advancements in the area of fertility and cryopreservation through cutting-edge research at Santa Monica Fertility.
Biography
After completing his bachelor's degree in classical Greek civilization, master’s in anatomy and cell biology and medical school at the University of Southern California, Dr. Jain entered residency in obstetrics and gynecology at the Los Angeles County + University of Southern California Medical Center. At the time, this residency program was the number one obstetrics and gynecology program in the United States. Jain was mentored by the Chairman of the Department, Dr. Daniel Mishell, a past president of the American Board of Obstetrics and Gynecology, the American Society for Reproductive Medicine and the Society of Gynecologic Investigation and author of the principal textbook used in the field of gynecology.
While he was still a junior resident in training, Jain published his first scientific paper in the New England Journal of Medicine. He received international acclaim for his seminal work on the use of misoprostol for family planning, a technique which has now become standard treatment for intrauterine fetal demise.
Jain was accepted to Fellowship in Reproductive Endocrinology and Infertility at the University of Southern California. By the end of his fellowship, Jain had published 15 scientific articles and abstracts and was invited to join the faculty of the Department of Obstetrics and Gynecology at the University of Southern California.
Jain was highly productive during his faculty years. He was awarded $6.5m in grants from the NIH, various foundations and pharmaceutical companies, more than all of the other faculty members in the department combined. His 2003 grant from the NIH, titled "The Effect of Nonoxynol-9 on Human Endometrium", was given one of the highest scores ever assigned by the National Institute of Human and Child Development, Center for Population Research. As a result of this grant, Jain was invited to be a member of the National Institute of Human and Child Development’s faculty for its conference on Maternal–Fetal-Neonatal-Reproductive Medicine held in Aspen, Colorado. The faculty of the conference, representative of the thought leaders and mentors in the field, were invited to give cutting-edge lectures and workshops to help train the next generation of academic physician scientists. Jain was also invited by the NIH to various steering groups on family planning, fertility preservation and as a grant reviewer for Small Business Innovative Research (SBIR).
While at the university, Jain performed an influential clinical trial on egg freezing. At the time of his work in 2004, there were fewer than 150 infants born worldwide from egg freezing technologies. The first four patients in his trial became pregnant from frozen eggs. Jain wrote an important review article on oocyte cryopreservation for the journal Fertility Sterility in 2006, identifying him as an expert in the area of fertility preservation. He was subsequently invited by the Today Show to appear in the studio and discuss egg freezing. The show was broadcast to an international audience of 30 million viewers. Thereafter, he was invited by the American Society for Reproductive Medicine to be one of the keynote presenters on a debate of egg freezing in 2009. The debate was moderated by the society's president and had a standing-room only crowd of nearly 1,000 delegates.
The University of Southern California granted Tenure to Jain in 2004, a rare accomplishment for a professor on a clinical, non-basic science track. Tenure was granted for his international impact on the field of family planning and fertility, his various teaching awards, and prolific publication and grants records. At the time of his departure from the University, Jain had over 100 scientific publications.
In 2007, Jain left the University to build Santa Monica Fertility, a state-of-the-art fertility center combining outstanding medical expertise, cutting-edge research and individualized attention to the patient’s mental and physical well-being in an integrative manner.
Santa Monica Fertility attracted national fame as the subject of a 2012 nationally broadcast documentary called My Future Baby. The documentary covered many aspects of infertility and featured Jain. It included experts from Harvard University, The University of Oxford and the President of the American Society for Reproductive Medicine. Jaine continues to be sought by national television and news organizations for his opinion and expertise. Hen is the most televised fertility specialist in the United States having been on national television fourteen times. He continues to be the fertility expert for the nationally broadcast show, The Doctors (2008 TV series)The Doctors.
More About John Jain, MD
Jain completed his BA in classical Greek civilization, MS in anatomy and cell biology, and MD from the University of Southern California. He also completed his specialty training in obstetrics and gynecology and subspecialty training in reproductive endocrinology and infertility at the University of Southern California, where he remained a full-time faculty member until 2007. His 25-year affiliation with the university included a decade as a tenured professor of obstetrics and gynecology at the University of Southern California's Keck School of Medicine. During his residency, Jain conducted the first research and published his findings on the use of RU486. Much of his early career was focused on contraceptive medicine and the use of pharmacologic agents to induce abortions. In 1987, Jain was part of the team of fertility physicians at USC that reported the first triplet pregnancy after frozen embryo transfer.[1]
His work on contraceptive research in the early 1990s took him to Fortaleza, Brazil. The global microbicides program of the NIH, and the contraceptive network established by the National Institute of Child Health and Human Development were among other research projects he was involved with and conducted at the University of Southern California. These programs aim to educate women regarding their health, fertility and reproduction, and to prevent the spread of HIV.
Jain also led egg freezing research at the institution, and subsequently created the university’s egg freezing program. In 2005, the USC team was the first in the US to announce a triplet pregnancy using frozen eggs.[2]
In 2007, Jain left the academic setting of USC and launched Santa Monica Fertility Specialists and Egg Freezing Center. Clinical trials published in 2008 yielded the first triple pregnancy using a vitrification method (as opposed to the traditional slow-freeze method).[3]
Jain is the founder and medical director of the Lyan Institute of Fertility Research (LIFE Research), a non-profit foundation dedicated to advancements in the science and application of fertility preservation technology for women, with a primary focus on the needs of reproductive-aged women diagnosed with cancer. Understanding the exact process by which cancer treatment destroys eggs and ovarian tissue is a focus of the work currently being conducted at LIFE.
Jain's clinic, Santa Monica Fertility, is a manifestation of his vision of patient care within the field of fertility, a practice that combines outstanding medical expertise, cutting-edge research and respectful, individualized attention to the patient’s mental and physical well-being, with one goal: to improve the likelihood of pregnancy and the birth of healthy babies.
Publications
Jain is the author of numerous scientific articles and chapters, including:
- Jain JK, Paulson RJ (October 2006). "Oocyte cryopreservation". Fertility and Sterility. 86 (4 Suppl): 1037–46. doi:10.1016/j.fertnstert.2006.07.1478. PMID 17008147.
- Jain, J.K.; Francis, M.M.; Bayrak, A.; Quinn, P.; Paulson, R.J. (2005). "Pregnancy Outcome After Cryopreservation of All Oocytes from a Single Ovulatory Cohort: A Prospective Clinical Trial". Fertility and Sterility. 84: S350–1. doi:10.1016/j.fertnstert.2005.07.917.
- Paulson RJ, Boostanfar R, Saadat P, et al. (November 2002). "Pregnancy in the sixth decade of life: obstetric outcomes in women of advanced reproductive age". JAMA. 288 (18): 2320–3. doi:10.1001/jama.288.18.2320. PMID 12425710.
- Jain JK (1999). "The future of assisted reproductive technologies". Whittier Law Review. 21: 435–42.
- Jain JK, Boostanfar R, Slater CC, Francis MM, Paulson RJ (April 2004). "Monozygotic twins and triplets in association with blastocyst transfer". Journal of Assisted Reproduction and Genetics. 21 (4): 103–7. PMC 3455608. PMID 15270208.
- Jain JK, Kuo J (September 2004). "Pregnancy outcomes with increased clomiphene citrate dose". Gynecological Endocrinology. 19 (3): 141–5. PMID 15697075.
See also
References
- ↑ KNBC.com June 15, 2005. Retrieved on August 4, 2008
- ↑ Los Angeles Times, July 18, 2005. Retrieved on August 4, 2008
- ↑ April 29, 2008. Retrieved on August 4, 2008
External links
- www.eggfreezingcenter.com
- American Society for Reproductive Medicine
- Fertile Hope
- World Health Organization - Microbicides
- Jain's Fertility Center
- Ovarian Reserve Testing